Evidence map›Paper›PMID 25595190›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2015

Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells.

David Contador, Fernando Ezquer, Maximiliano Espinosa, Martha Arango-Rodriguez, Carlos Puebla, Luis Sobrevia, Paulette Conget

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

David ContadorCenter for Regenerative Medicine, School of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile dcontador@udd.cl.
Fernando EzquerCenter for Regenerative Medicine, School of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile.
Maximiliano EspinosaCenter for Regenerative Medicine, School of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile.
Martha Arango-RodriguezCenter for Regenerative Medicine, School of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile.
Carlos PueblaCellular and Molecular Physiology Laboratory, Obstetrics and Gynecology Division, Faculty of Medicine, P. Universidad Católica de Chile, Santiago 8330024, Chile.
Luis SobreviaCellular and Molecular Physiology Laboratory, Obstetrics and Gynecology Division, Faculty of Medicine, P. Universidad Católica de Chile, Santiago 8330024, Chile.
Paulette CongetCenter for Regenerative Medicine, School of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile.
Clínica Alemana · CLPontificia Universidad Católica de Chile · CLUniversidad del Desarrollo · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The final product of adipogenesis is a functional adipocyte. This mature cell acquires the necessary machinery for lipid metabolism, loses its proliferation potential, increases its insulin sensitivity, and secretes adipokines. Multipotent mesechymal stromal cells have been recognized as a source of adipocytes both in vivo and in vitro. The in vitro adipogenic differentiation of human MSC (hMSC) has been induced up to now by using a complex stimulus which includes dexamethasone, 3-isobutyl-1-methylxanthine, indomethacin, and insulin (a classical cocktail) and evaluated according to morphological changes. The present work was aimed at demonstrating that the simultaneous activation of dexamethasone's canonical signaling pathways, through the glucocorticoid receptor and CCAAT-enhancer-binding proteins (C/EBPs) and rosiglitazone through peroxisome proliferator-activated receptor gamma (PPAR-gamma) is sufficient yet necessary for inducing hMSC adipogenic differentiation. It was also ascertained that hMSC exposed just to dexamethasone and rosiglitazone (D&R) differentiated into cells which accumulated neutral lipid droplets, expressed C/EBP-alpha, PPAR-gamma, aP2, lipoprotein lipase, acyl-CoA synthetase, phosphoenolpyruvate carboxykinase, adiponectin, and leptin genes but did not proliferate. Glucose uptake was dose dependent on insulin stimulus and high levels of adipokines were secreted (i.e. displaying not only the morphology but also expressing mature adipocytes' specific genes and functional characteristics). This work has demonstrated that (i) the activating C/EBPs and PPAR-gamma signaling pathways were sufficient to induce adipogenic differentiation from hMSC, (ii) D&R producing functional adipocytes from hMSC, (iii) D&R induce adipogenic differentiation from mammalian MSC (including those which are refractory to classical adipogenic differentiation stimuli). D&R would thus seem to be a useful tool for MSC characterization, studying adipogenesis pathways and producing functional adipocytes.

Indexed as

AdipocytesAdipogenesisAnilidesAnimalsCCAAT-Enhancer-Binding ProteinsCell DifferentiationCricetinaeDexamethasoneDogsHumansIn Vitro TechniquesMesenchymal Stem CellsMesocricetusMiceMice, Inbred C57BLMifepristone2-chloro-5-nitrobenzanilideAnilidesCCAAT-Enhancer-Binding ProteinsDexamethasoneMifepristonePPAR gammaReceptors, GlucocorticoidRNA, MessengerRosiglitazoneThiazolidinedionesAdipogenesisadipogenic differentiationadipokinefunctional adipocytemesechymal stem cellmultipotent stromal cell

Identifiers

PMID25595190
PMCPMC4935363
OpenAlexW1988149035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.